A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising

Detalles Bibliográficos
Autores principales: Burton, Paul, Peacock, W. Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419767/
https://www.ncbi.nlm.nih.gov/pubmed/28491680
http://dx.doi.org/10.1016/j.hrcr.2016.02.001
_version_ 1783234271289278464
author Burton, Paul
Peacock, W. Frank
author_facet Burton, Paul
Peacock, W. Frank
author_sort Burton, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-5419767
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54197672017-05-10 A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising Burton, Paul Peacock, W. Frank HeartRhythm Case Rep Case Report Elsevier 2016-02-16 /pmc/articles/PMC5419767/ /pubmed/28491680 http://dx.doi.org/10.1016/j.hrcr.2016.02.001 Text en © 2016 Heart Rhythm Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Burton, Paul
Peacock, W. Frank
A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title_full A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title_fullStr A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title_full_unstemmed A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title_short A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
title_sort medwatch review of reported events in patients who discontinued rivaroxaban (xarelto) therapy in response to legal advertising
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419767/
https://www.ncbi.nlm.nih.gov/pubmed/28491680
http://dx.doi.org/10.1016/j.hrcr.2016.02.001
work_keys_str_mv AT burtonpaul amedwatchreviewofreportedeventsinpatientswhodiscontinuedrivaroxabanxareltotherapyinresponsetolegaladvertising
AT peacockwfrank amedwatchreviewofreportedeventsinpatientswhodiscontinuedrivaroxabanxareltotherapyinresponsetolegaladvertising
AT burtonpaul medwatchreviewofreportedeventsinpatientswhodiscontinuedrivaroxabanxareltotherapyinresponsetolegaladvertising
AT peacockwfrank medwatchreviewofreportedeventsinpatientswhodiscontinuedrivaroxabanxareltotherapyinresponsetolegaladvertising

Ejemplares similares